Legal Solutions to Support and Safeguard Global Product Launch

Get Help from Our Practice Groups Specialized in Pharma, Biotech, and Medical Devices

Learn More
Digital legal

TransPerfect Legal Solutions

Patent Translation & Foreign Filing

We simplify the patent translation and global filing process with our suite of comprehensive solutions for patent-related needs. TLS’s dedicated project managers, expert patent specialists, and highly qualified linguist pool help reduce translation costs, agency fees, administrative burdens, and turnaround times—without sacrificing quality or service.

Learn More

Litigation Support

When it comes to investigations and litigation support, TLS helps mitigate the challenges associated with e-discovery, privacy, and information security, and provides visibility into the discovery management process.

Learn More

Achieve Greatness in the Global Regulatory Landscape

Today, global sponsors are consistently challenged to bring products to market faster while facing evolving regulations with increased scrutiny. With the language barriers and collaboration logistics of global operations, clinical trials must be managed carefully to avoid unexpected increases in cost, time, and compliance risk. Having a global partner like TransPerfect by your side helps you focus on what matters most: saving lives.

Artificial Intelligence in Life Sciences

Latest Developments Presented by Industry Leaders

Improved Outcomes by the Numbers

Avoid challenges in bringing therapeutic products to market by protecting intellectual property and effectively navigating international legal matters.

  • Cut down high-volume data sets in multiple languages within stringent turnaround times
  • Rapidly collect, review, and produce discovery data from multiple custodians
  • Provide insights into potential threats and protect against data breaches
  • Translate and file a patent in 20 different countries

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in conducting clinical research.

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

By February 27, 2027, medical device manufacturers must upload their validated, translated Summaries of Safety and Clinical Performance (SSCPs) to EUDAMED themselves. IVD manufacturers have the same responsibility for their Summaries of Safety and Performance (SSPs). That’s a lot of documents, in a lot of languages, with a short and rapidly approaching upload window. This deadline came up repeatedly at the recent RAPS Convergence Conference in Charlotte, NC, mostly in ...

MDR SSCPs and IVDR SSPs Are NOT Labeling: What That Means for Your EUDAMED Upload

Are Legacy COA Instruments Still Fit for Purpose?

The following insights are synthesized from TransPerfect LifeSci Talks, hosted by Mark P. Wade, Practice Leader COA SME at TransPerfect Life Sciences, with guest Kathrin Fischer, PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and board member of ISOQOL....

The Human in the Vault: Building Review Workflows That Satisfy Regulators

AI translation is already fast enough for most teams. The gap is on the review side: who signs off, what gets logged, and whether the process holds up when a regulator asks. This session walks through a real human review workflow within an AI-assisted translation process ...

eConsent: Why the Content Matters as Much as the Tech

Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind...

Pragmatic Use Cases for AI in Medical Information

The rapid advancement of AI presents medical information teams with powerful new opportunities to transform their operations. From inquiry intake and intelligent triage to case management and standard response development, AI-driven solutions are already delivering measurable ...

LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients

Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, ...

Has eCOA Lived up to Its Promise? A Retrospective View on the Evolution of Electronic Clinical Outcome Assessments

The Evolution of eCOA: Progress, Challenges, and the Road AheadElectronic clinical outcome assessments (eCOAs) were expected to make paper obsolete by improving data quality, reducing missing data, and enabling decentralized clinical trials.More than two decades later, that...

Get Global Legal Support.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.